The inflammatory bowel disease questionnaire: A review of its national validation studies

Inflammatory Bowel Diseases

Volumn 10, Issue 3, 2004, Pages 261-269

  Pallis, A G ^a   Mouzas, Ionnis A ^a   Vlachonikolis, I G ^b  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^b UNIVERSITY OF CRETE   (Greece)

Author keywords

Crohn's disease; Health related quality of life; Inflammatory bowel disease; Inflammatory bowel disease questionnaire; Ulcerative colitis

Indexed keywords

CHINA; CLINICAL STUDY; CROHN DISEASE; DATA BASE; ENTERITIS; GREECE; HUMAN; INTERMETHOD COMPARISON; INTERVIEW; KOREA; LINGUISTICS; MEDLINE; NETHERLANDS; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RELIABILITY; RETROSPECTIVE STUDY; REVIEW; SELF EVALUATION; SENSITIVITY AND SPECIFICITY; SPAIN; STANDARD; STATISTICAL ANALYSIS; SWEDEN; ULCERATIVE COLITIS; UNITED KINGDOM; VALIDATION PROCESS; VISUAL ANALOG SCALE;

HEALTH STATUS; HEALTH STATUS INDICATORS; HUMANS; INFLAMMATORY BOWEL DISEASES; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 2442560536     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1097/00054725-200405000-00014     Document Type: Review

References (38)

1. Guyatt G, Mitchell A, Irvine EJ, et al. A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology. 1989;96: 804-810.
2. Mitchell A, Guyatt G, Singer J, et al. Quality of life in patients with inflammatory bowel disease. J Clin Gastroenterol. 1988;10:306-310.
3. Irvine EJ. Quality of Life - measurement in inflammatory bowel disease. Scand J Gastroenterol Suppl. 1993;199:36-39.
4. Irvine EJ, Feagan BG, Wong CJ. Does self-administration of a quality of life index for inflammatory bowel disease change the results? J Clin Epidemiol. 1996;49:1177-1185.
5. Irvine EJ, Zhou Q, Thompson AK. The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators. Canadian Crohn's Relapse Prevention Trial. Am. J. Gastroenterol. 1996;91:1571-1578.
6. Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med. 1993;118:622-629.
7. Guillemin F, Bombardier C, Beaton D. Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol. 1993;46:1417-1432.
8. Assessing health status and quality-of-life instruments: attributes and review criteria. Qual Life Res. 2002;11(3):193-205.
9. MAPI Research Institute. Cultural adaptation of quality of life instruments. Qual Life Newslett. 1997;18:10-11.
10. Han SW, McColl E, Steen N, et al. The inflammatory bowel disease questionnaire: a valid and reliable measure in ulcerative colitis patients in the North East of England. Scand J Gastroenterol. 1998;33:961-966.
11. Cheung WY, Garratt AM, Russell IT, et al. The UK IBDQ-a British version of the inflammatory bowel disease questionnaire. development and validation. J Clin Epidemiol. 2000;53:297-306.
12. de Boer AG, Wijker W, Bartelsman JF, et al. Inflammatory Bowel Disease Questionnaire: cross-cultural adaptation and further validation. Eur J Gastroenterol Hepatol. 1995;7:1043-1050.
13. Russel MG, Pastoor CJ, Brandon S, et al. Validation of the Dutch translation of the Inflammatory Bowel Disease Questionnaire (IBDQ): a health-related quality of life questionnaire in inflammatory bowel disease. Digestion. 1997;58:282-288.
14. Kim WH, Cho YS, Yoo HM, et al. Quality of life in Korean patients with inflammatory bowel diseases: ulcerative colitis, Crohn's disease and intestinal Behcet's disease. Int J Colorectal Dis. 1999;14:52-57.
15. Lopez-Vivancos J, Casellas F, Badia X, et al. Validation of the spanish version of the inflammatory bowel disease questionnaire on ulcerative colitis and Crohn's disease. Digestion. 1999;60:274-280.
16. Hjortswang H, Jarnerot G, Curman B, et al. Validation of the inflammatory bowel disease questionnaire in Swedish patients with ulcerative colitis. Scand J Gastroenterol. 2001;36:77-85.
17. Pallis AG, Vlachonikolis IG, Mouzas IA. Quality of life of Greek patients with inflammatory bowel disease. Validation of the Greek translation of the inflammatory bowel disease questionnaire. Digestion. 2001;63:240-246.
18. Leong RW, Lee YT, Ching JY, et al. Quality of life in Chinese patients with inflammatory bowel disease: validation of the Chinese translation of the Inflammatory Bowel Disease Questionnaire. Aliment Pharmacol Ther. 2003;17:711-718.
19. Love JR, Irvine EJ, Fedorak RN. Quality of life in inflammatory bowel disease. J Clin Gastroenterol. 1992;14:15-19.
20. Irvine EJ, Feagan B, Rochon J, et al. Quality of life: a valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Canadian Crohn's Relapse Prevention Trial Study Group. Gastroenterology. 1994;106:287-296.
21. Stewart AL, Greenfield S, Hays RD, et al: Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study. JAMA. 1989;262:907-913.
22. Stewart AL, Hays RD, Ware JE Jr. The MOS short-form general health survey. Reliability and validity in a patient population. Med Care. 1988; 26:724-735.
23. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385-401.
24. Sherbourne CD, Stewart AL. The MOS social support survey. Soc Sci Med. 1991;32:705-714.
25. Sherbourne CD, Meredith LS, Rogers W, et al. Social support and stressful life events: age differences in their effects on health-related quality of life among the chronically ill. Qual Life Res. 1992;1:235-246.
26. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992; 30:473-483.
27. Harvey RF, Bradshaw JM. A simple index of Crohn's-disease activity. Lancet. 1980;1:514.
28. Levenstein S, Prantera C, Varvo V, et al. Psychological stress and disease activity in ulcerative colitis: a multidimensional cross-sectional study. Am J Gastroenterol. 1994;89:1219-1225.
29. Lichtiger S, Present DH, Kornbluth A, et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med. 1994;330: 1841-1845.
30. Powell-Tuck J, Day DW, Buckell NA, et al. Correlations between defined sigmoidoscopic appearances and other measures of disease activity in ulcerative colitis. Dig Dis Sci. 1982;27:533-537.
31. Best WR, Becktel JM, Singleton JW, et al. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology. 1976;70:439-444.
32. Dupuy HJ. The Psychological General Well-Being (PGWB) Index. In: Wegner NK, Mattson ME, Fuberg CP, eds. Assessment of Quality of LIfe in Clinical trials of Cardiovascular Therapies. New York: Le Jacq, 1984.
33. The EuroQol Group. EuroQol - a new facility for the measurement of health-related quality of life. Health Policy. 1990;16:199-208.
34. Rachmilewitz D. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. BMJ. 1989;298:82-86.
35. Drossman DA, Leserman J, Li ZM, et al. The rating form of IBD patient concerns: a new measure of health status. Psychosom Med. 1991;53:701-712.
36. Baron JH, Connell AM, Lennard-Jones JE. Variation between observers in describing mucosal appearances in proctocolitis. BMJ. 1964;1:89-96.
37. Ginsberg AL, Beck LS, McIntosh TM, et al. Treatment of left-sided ulcerative colitis with 4-aminosalicylic acid enemas. A double-blind, placebo-controlled trial. Ann Intern Med. 1988;108:195-199.
38. Mardia KV, Kent JT, Bibby JM. Multivariate Analysis. London: Academic Press 1982.